These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24358058)

  • 1. Design, Synthesis and Biological Evaluation of N4-Sulfonamido-Succinamic, Phthalamic, Acrylic and Benzoyl Acetic Acid Derivatives as Potential DPP IV Inhibitors.
    Khalaf RA; Sheikha GA; Al-Sha'er M; Taha M
    Open Med Chem J; 2013; 7():39-48. PubMed ID: 24358058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors.
    Khalaf RA; Sabbah D; Al-Shalabi E; Al-Sheikh I; Albadawi G; Abu Sheikha G
    Curr Comput Aided Drug Des; 2018; 14(2):142-151. PubMed ID: 29521244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM; Mohammad MK; Taha MO
    ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenanthridine Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Design, Synthesis and Biological Evaluation.
    Khalaf RA; Alqazaqi S; Aburezeq M; Sabbah D; Albadawi G; Sheikha GA
    Curr Comput Aided Drug Des; 2022; 18(1):9-25. PubMed ID: 33030135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE; Salsali A
    Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
    Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M
    J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.
    Singh AK; Jatwa R; Purohit A; Ram H
    J Asian Nat Prod Res; 2017 Oct; 19(10):1036-1045. PubMed ID: 28351157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes.
    Green BD; Flatt PR; Bailey CJ
    Expert Opin Emerg Drugs; 2006 Sep; 11(3):525-39. PubMed ID: 16939389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
    Almasri IM; Taha MO; Mohammad MK
    Arch Pharm Res; 2013 Nov; 36(11):1326-37. PubMed ID: 23918649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
    Xie Y; Shao L; Wang Q; Bai Y; Chen Z; Li N; Xu Y; Li Y; Yang G; Bian X
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3731-3735. PubMed ID: 30343953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
    Duffy NA; Green BD; Irwin N; Gault VA; McKillop AM; O'Harte FP; Flatt PR
    Eur J Pharmacol; 2007 Jul; 568(1-3):278-86. PubMed ID: 17573070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
    Deng X; Han L; Zhou J; Zhang H; Li Q
    Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme.
    Al-Balas QA; Sowaileh MF; Hassan MA; Qandil AM; Alzoubi KH; Mhaidat NM; Almaaytah AM; Khabour OF
    Drug Des Devel Ther; 2014; 8():129-63. PubMed ID: 24470754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephedrine as a lead compound for the development of new DPP-IV inhibitors.
    Ojeda-Montes MJ; Ardid-Ruiz A; Tomás-Hernández S; Gimeno A; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Garcia-Vallvé S; Pujadas G; Valls C
    Future Med Chem; 2017 Dec; 9(18):2129-2146. PubMed ID: 29172693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Biological Evaluation, and Molecular Docking of (R)-2-((8-(3-aminopiperidin-1-yl)-3-methyl-7-(3-methylbut-2-en-1-yl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzonitrile as Dipeptidyl Peptidase IV Inhibitors.
    Ran Y; Pei H; Shao M; Chen L
    Chem Biol Drug Des; 2016 Feb; 87(2):290-5. PubMed ID: 26426933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.